Antipsychotic medication

The Nature of Relapse in Schizophrenia

Discontinuation of treatment in schizophrenia results in very high relapse rates, even after a single psychotic episode. A new review […]

Read More
DETAIL

Beyond Dopamine: Glutamate as a Target in Schizophrenia

An interesting review in ISRN Pharmacology, a peer-reviewed, open access journal, describes that for the last 60 years, antipsychotic pharmacology […]

Read More
DETAIL

Non-adherence to Antipsychotics and Cardiometabolic Medication Result in Health Care Utilization and Costs

A new study in Psychiatric Services examined the association between adherence to antipsychotic and cardiometabolic medication and the use of […]

Read More
DETAIL

Impact of Preexisting Metabolic Risk Factors on the Choice of Antipsychotics

A study in this month’s Psychiatric Services examined the association between patients’ preexisting metabolic risk factors and the physician’s choice […]

Read More
DETAIL

Psychiatrists fail to monitor patients for metabolic side-effects of medication

According to a new study in Psychological Medicine, people treated in psychiatric settings are receiving inadequate medical monitoring while taking […]

Read More
DETAIL